Supernus Pharmaceuticals
SUPN
SUPN
265 hedge funds and large institutions have $2.07B invested in Supernus Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 101 increasing their positions, 94 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8% more funds holding
Funds holding: 246 → 265 (+19)
4.33% more ownership
Funds ownership: 91.94% → 96.27% (+4.3%)
7% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 94
Holders
265
Holding in Top 10
8
Calls
$13.2M
Puts
$9.15M
Top Buyers
| 1 | +$42.4M | |
| 2 | +$32.1M | |
| 3 | +$24.8M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$21.5M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$17.6M |
Top Sellers
| 1 | -$24.3M | |
| 2 | -$17.5M | |
| 3 | -$15.9M | |
| 4 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$11M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$9.02M |